Economic Shifts and Vaccine Controversies

This chapter explores the fluctuating economic landscape during the second Trump administration, particularly regarding tariffs on European goods and the subsequent rise in market confidence. It also addresses a contentious change in vaccine recommendations by Health and Human Services, questioning the impact on public health standards and insurance coverage. Experts weigh in on both topics, highlighting their implications for trade negotiations and healthcare accessibility.